Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla
Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla
复制标题
DOI:
10.1081/jcmr-200053588
复制
发表时间:
2005-04-01
影响因子:
6.4
通讯作者:
Forder, JR
中科院分区:
文献类型:
--
作者:
Shellock, FG;Forder, JR
Purpose. To evaluate MR safety at 3 Tesla for a drug eluting coronary stent. Methods. A drug eluting coronary stent ( Endeavor, cobalt alloy, Medtronic Vascular, Santa Rosa, CA) was evaluated for magnetic field interactions, heating, and artifacts at 3 Tesla. MRI-related heating was assessed with the stent in a gelled saline-filled phantom using a transmit/received RF body coil with a whole body averaged SAR of 2.0 W/kg. Artifacts were characterized using T1-weighted, spin echo, and gradient echo pulse sequences. Results. The stent exhibited minor magnetic field interactions that will not cause migration. Heating was not substantial (+ 0.5 degrees C). Artifacts may create a problem if the area of interest is in the same area or close to the stent ( e. g., for a T1-weighted, spin echo pulse sequence, within approximately 16 mm; for a gradient echo pulse sequence, within approximately 23 mm). Conclusion. The findings indicated that it would be safe for a patient with this cobalt alloy-based, drug-eluting coronary stent to undergo MRI at 3 Tesla or less. Importantly, because of the relative lack of magnetic field interactions, MRI may be performed immediately after implantation.